New-onset anxiety in adults aged 50+ doubles risk of developing Parkinson’s disease

FHS
June 27, 2024
7:49 am

Researchers investigated Parkinson’s disease (PD) risk among individuals with new-onset anxiety and associated risk factors.

Senate Probe of Births in Prisons Exposes ‘Pervasive Abuse and Mistreatment’

An investigation into jail and prison conditions for pregnant and postpartum women revealed dangerous, unsanitary, and inhumane conditions, according to the Senate Judiciary Subcommittee on

August 2, 2024

Tenecteplase by Genentech USA for Acute Respiratory Failure: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

June 14, 2024

Formycon Ranibizumab Biosimilar FYB201/CIMERLI® achieved a market share of 38% in the United States in December 2023 – Biotech Investments

EQS-News: Formycon AG / Key word(s): Market Report Formycon Ranibizumab Biosimilar FYB201/CIMERLI® achieved a market share of 38% in the United States in December 2023

January 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.